Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Inhibition of vascular endothelial growth factor in young adult mice causes low bone blood flow and bone strength with no effect on bone mass in trabecular regions.

Lane NE, Nyman JS, Uppuganti S, Chaudhari AJ, Aguirre JI, Shidara K, Liu XP, Yao W, Kimmel DB.

Bone Rep. 2019 May 11;10:100210. doi: 10.1016/j.bonr.2019.100210. eCollection 2019 Jun.

2.

Strain-specific differences in the development of bone loss and incidence of osteonecrosis following glucocorticoid treatment in two different mouse strains.

Shidara K, Mohan G, Evan Lay YA, Jepsen KJ, Yao W, Lane NE.

J Orthop Translat. 2018 Jul 27;16:91-101. doi: 10.1016/j.jot.2018.07.001. eCollection 2019 Jan.

3.

Prevalence of glucocorticoid induced osteonecrosis in the mouse is not affected by treatments that maintain bone vascularity.

Lane NE, Mohan G, Yao W, Shidara K, Lay YE, Junjing J, Dubrovsky A, Kimmel DB.

Bone Rep. 2018 Nov 3;9:181-187. doi: 10.1016/j.bonr.2018.10.003. eCollection 2018 Dec.

4.

Switching from concomitant therapy to tafluprost/timolol fixed combination.

Inoue K, Kawashima T, Katakura S, Shidara K, Fujimoto T, Kohmoto H, Shiokawa M, Moriyama R, Okayama R.

Clin Ophthalmol. 2018 Mar 21;12:549-554. doi: 10.2147/OPTH.S150595. eCollection 2018.

5.

Incidence of comprehensive hospitalization due to infection, cardiovascular disease, fractures, and malignancies in patients with rheumatoid arthritis.

Sugimoto N, Nakajima A, Inoue E, Shidara K, Yamashita H, Mimori A, Tokuda H, Seto Y, Tanaka E, Momohara S, Taniguchi A, Yamanaka H.

Rheumatol Int. 2017 Nov;37(11):1871-1878. doi: 10.1007/s00296-017-3811-5. Epub 2017 Sep 7.

PMID:
28884287
6.

Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort.

Shimizu Y, Tanaka E, Inoue E, Shidara K, Sugimoto N, Seto Y, Nakajima A, Momohara S, Taniguchi A, Yamanaka H.

Mod Rheumatol. 2018 May;28(3):461-467. doi: 10.1080/14397595.2017.1369926. Epub 2017 Sep 14.

PMID:
28880684
7.

Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort.

Shimizu Y, Nakajima A, Inoue E, Shidara K, Sugimoto N, Seto Y, Tanaka E, Momohara S, Taniguchi A, Yamanaka H.

Clin Rheumatol. 2017 Jun;36(6):1237-1245. doi: 10.1007/s10067-017-3634-5. Epub 2017 Apr 28.

PMID:
28455827
8.

Osteoarthritis year in review 2016: clinical.

Lane NE, Shidara K, Wise BL.

Osteoarthritis Cartilage. 2017 Feb;25(2):209-215. doi: 10.1016/j.joca.2016.09.025. Epub 2017 Jan 16. Review.

9.

Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis.

Shidara K, Nakajima A, Inoue E, Hoshi D, Sugimoto N, Seto Y, Tanaka E, Momohara S, Taniguchi A, Yamanaka H.

J Rheumatol. 2017 Feb;44(2):147-153. doi: 10.3899/jrheum.160395. Epub 2016 Dec 1.

PMID:
27909083
10.

The minimally important difference for the Japanese version of the health assessment questionnaire in patients with rheumatoid arthritis in daily practice.

Shidara K, Nakajima A, Inoue E, Hoshi D, Sugimoto N, Seto Y, Tanaka E, Ikari K, Taniguchi A, Yamanaka H.

Mod Rheumatol. 2017 May;27(3):430-434. doi: 10.1080/14397595.2016.1213490. Epub 2016 Oct 21.

PMID:
27766911
11.

Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in Japan.

Tanaka E, Inoue E, Yamaguchi R, Shimizu Y, Kobayashi A, Sugimoto N, Hoshi D, Shidara K, Sato E, Seto Y, Nakajima A, Momohara S, Taniguchi A, Yamanaka H.

Mod Rheumatol. 2017 Mar;27(2):227-236. doi: 10.1080/14397595.2016.1205799. Epub 2016 Jul 29.

PMID:
27472516
12.

Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA database.

Hoshi D, Tanaka E, Igarashi A, Inoue E, Kobayashi A, Sugimoto N, Shidara K, Sato E, Seto Y, Nakajima A, Momohara S, Taniguchi A, Tsutani K, Yamanaka H.

Mod Rheumatol. 2016;26(1):40-5. doi: 10.3109/14397595.2015.1059983. Epub 2015 Jul 20.

PMID:
26052801
13.

Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012.

Sato E, Tanaka E, Ochiai M, Shimizu Y, Kobayashi A, Shidara K, Hoshi D, Sugimoto N, Inoue E, Seto Y, Nakajima A, Taniguchi A, Momohara S, Yamanaka H.

Mod Rheumatol. 2015 May;25(3):350-7. doi: 10.3109/14397595.2014.958274. Epub 2015 Jan 25.

PMID:
25619283
14.

Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study.

Tanaka E, Inoue E, Hoshi D, Shimizu Y, Kobayashi A, Sugimoto N, Shidara K, Sato E, Seto Y, Nakajima A, Momohara S, Taniguchi A, Yamanaka H.

Mod Rheumatol. 2015 Jul;25(4):503-13. doi: 10.3109/14397595.2014.1001475. Epub 2015 Feb 11.

PMID:
25547018
15.

Assessment of the effectiveness of golimumab 50-mg and 100-mg regimens in patients with rheumatoid arthritis in daily practice.

Sato E, Tanaka E, Nakajima A, Inoue E, Shimizu Y, Yamaguchi R, Ochiai M, Shidara K, Hoshi D, Sugimoto N, Seto Y, Taniguchi A, Momohara S, Yamanaka H.

Mod Rheumatol. 2015 Jul;25(4):528-33. doi: 10.3109/14397595.2014.995892. Epub 2015 Feb 9.

PMID:
25536168
16.

Successful Treatment of Hepatitis B Virus-associated Membranous Nephropathy with Entecavir and Immunosuppressive Agents.

Ochi A, Ishimura E, Ichii M, Ohno Y, Nakatani S, Kobayashi I, Shima H, Tsuda A, Shidara K, Mori K, Tamori A, Inaba M.

Nephrology (Carlton). 2014 Sep;19(9):595-6. doi: 10.1111/nep.12292. No abstract available.

PMID:
25156438
17.

Presence of comorbidity affects both treatment strategies and outcomes in disease activity, physical function, and quality of life in patients with rheumatoid arthritis.

Nakajima A, Inoue E, Shimizu Y, Kobayashi A, Shidara K, Sugimoto N, Seto Y, Tanaka E, Taniguchi A, Momohara S, Yamanaka H.

Clin Rheumatol. 2015 Mar;34(3):441-9. doi: 10.1007/s10067-014-2750-8. Epub 2014 Jul 31.

PMID:
25073613
18.

A case of anterior ischemic optic neuropathy associated with uveitis.

Sugahara M, Fujimoto T, Shidara K, Inoue K, Wakakura M.

Clin Ophthalmol. 2013;7:1023-6. doi: 10.2147/OPTH.S42678. Epub 2013 May 29.

19.

Disability is the major negative predictor for achievement of Boolean-based remission in patients with rheumatoid arthritis treated with tocilizumab.

Hoshi D, Nakajima A, Shidara K, Seto Y, Tanaka E, Taniguchi A, Momohara S, Yamanaka H.

Mod Rheumatol. 2013 Nov;23(6):1205-10. doi: 10.1007/s10165-012-0825-4. Epub 2013 Mar 2.

PMID:
23456321
20.

Functional disability can deteriorate despite suppression of disease activity in patients with rheumatoid arthritis: a large observational cohort study.

Seto Y, Inoue E, Shidara K, Hoshi D, Sugimoto N, Sato E, Tanaka E, Nakajima A, Taniguchi A, Momohara S, Yamanaka H.

Mod Rheumatol. 2013 Nov;23(6):1179-85. doi: 10.1007/s10165-012-0816-5. Epub 2013 Jan 16.

PMID:
23319067
21.

Analysis of direct medical and nonmedical costs for care of rheumatoid arthritis patients using the large cohort database, IORRA.

Tanaka E, Hoshi D, Igarashi A, Inoue E, Shidara K, Sugimoto N, Sato E, Seto Y, Nakajima A, Momohara S, Taniguchi A, Tsutani K, Yamanaka H.

Mod Rheumatol. 2013 Jul;23(4):742-51. doi: 10.1007/s10165-012-0729-3. Epub 2012 Aug 10.

PMID:
22878927
22.

The influence of individual joint impairment on functional disability in rheumatoid arthritis using a large observational database of Japanese patients.

Shidara K, Inoue E, Hoshi D, Tanaka E, Seto Y, Nakajima A, Momohara S, Taniguchi A, Yamanaka H.

J Rheumatol. 2012 Mar;39(3):476-80. doi: 10.3899/jrheum.110770. Epub 2012 Jan 15.

PMID:
22247366
23.

Leber's hereditary optic neuropathy with the 3434, 9011 mitochondrial DNA point mutation.

Shidara K, Wakakura M.

Jpn J Ophthalmol. 2012 Mar;56(2):175-80. doi: 10.1007/s10384-011-0106-3. Epub 2011 Dec 20.

PMID:
22183138
24.

Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients.

Kobayashi I, Shidara K, Okuno S, Yamada S, Imanishi Y, Mori K, Ishimura E, Shoji S, Yamakawa T, Inaba M.

Life Sci. 2012 Jan 30;90(5-6):212-8. doi: 10.1016/j.lfs.2011.11.006. Epub 2011 Dec 1.

PMID:
22154904
25.

Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study).

Takeuchi T, Tanaka Y, Kaneko Y, Tanaka E, Hirata S, Kurasawa T, Kubo S, Saito K, Shidara K, Kimura N, Nagasawa H, Kameda H, Amano K, Yamanaka H.

Mod Rheumatol. 2012 Jun;22(3):327-38. doi: 10.1007/s10165-011-0516-6. Epub 2011 Sep 7.

26.

Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab.

Hoshi D, Nakajima A, Inoue E, Shidara K, Sato E, Kitahama M, Seto Y, Tanaka E, Urano W, Ichikawa N, Koseki Y, Momohara S, Taniguchi A, Nishimoto N, Yamanaka H.

Mod Rheumatol. 2012 Feb;22(1):122-7. doi: 10.1007/s10165-011-0488-6. Epub 2011 Jul 8.

PMID:
21735355
27.

Standard treatment in daily clinical practice for early rheumatoid arthritis improved disease activity from 2001 to 2006.

Nakajima A, Inoue E, Shidara K, Hoshi D, Sato E, Seto Y, Tanaka E, Taniguchi A, Momohara S, Yamanaka H.

Mod Rheumatol. 2011 Dec;21(6):594-7. doi: 10.1007/s10165-011-0457-0. Epub 2011 Apr 23.

PMID:
21516373
28.

Anti-cyclic citrullinated peptide antibody predicts functional disability in patients with rheumatoid arthritis in a large prospective observational cohort in Japan.

Shidara K, Inoue E, Hoshi D, Sato E, Nakajima A, Momohara S, Taniguchi A, Yamanaka H.

Rheumatol Int. 2012 Feb;32(2):361-6. doi: 10.1007/s00296-010-1671-3. Epub 2010 Nov 27.

PMID:
21113712
29.

Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA.

Nakajima A, Inoue E, Tanaka E, Singh G, Sato E, Hoshi D, Shidara K, Hara M, Momohara S, Taniguchi A, Kamatani N, Yamanaka H.

Scand J Rheumatol. 2010;39(5):360-7. doi: 10.3109/03009741003604542.

PMID:
20476859
30.

Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA.

Shidara K, Hoshi D, Inoue E, Yamada T, Nakajima A, Taniguchi A, Hara M, Momohara S, Kamatani N, Yamanaka H.

Mod Rheumatol. 2010 Jun;20(3):280-6. doi: 10.1007/s10165-010-0280-z. Epub 2010 Mar 10.

PMID:
20217173
31.

Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis.

Shidara K, Inoue E, Tanaka E, Hoshi D, Seto Y, Nakajima A, Momohara S, Taniguchi A, Yamanaka H.

Rheumatol Int. 2011 May;31(5):617-22. doi: 10.1007/s00296-009-1336-2. Epub 2010 Jan 5.

PMID:
20049446
32.

Cerebral microbleeds in predialysis patients with chronic kidney disease.

Shima H, Ishimura E, Naganuma T, Yamazaki T, Kobayashi I, Shidara K, Mori K, Takemoto Y, Shoji T, Inaba M, Okamura M, Nakatani T, Nishizawa Y.

Nephrol Dial Transplant. 2010 May;25(5):1554-9. doi: 10.1093/ndt/gfp694. Epub 2009 Dec 27.

PMID:
20037183
33.

Renal biopsy in a patient with haemophilia A and cryoglobulinaemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection.

Kobayashi I, Ishimura E, Hirowatari K, Tsuchida T, Nishihira A, Shima H, Shidara K, Mori K, Inaba M, Wakasa K, Nishizawa Y.

NDT Plus. 2009 Oct;2(5):373-5. doi: 10.1093/ndtplus/sfp072. Epub 2009 Jun 22.

34.

[Bone metabolic marker for osteoporosis].

Shidara K, Inaba M.

Nihon Rinsho. 2009 May;67(5):927-31. Review. Japanese.

PMID:
19432111
35.

Association of glycated albumin, but not glycated hemoglobin, with peripheral vascular calcification in hemodialysis patients with type 2 diabetes.

Yamada S, Inaba M, Shidara K, Okada S, Emoto M, Ishimura E, Nishizawa Y.

Life Sci. 2008 Sep 26;83(13-14):516-9. doi: 10.1016/j.lfs.2008.08.001. Epub 2008 Aug 9.

PMID:
18760286
36.

Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients.

Shidara K, Inaba M, Okuno S, Yamada S, Kumeda Y, Imanishi Y, Yamakawa T, Ishimura E, Nishizawa Y.

Calcif Tissue Int. 2008 Apr;82(4):278-87. doi: 10.1007/s00223-008-9127-4. Epub 2008 Apr 18.

PMID:
18421493
37.

Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.

Yamada S, Inaba M, Kurajoh M, Shidara K, Imanishi Y, Ishimura E, Nishizawa Y.

Clin Endocrinol (Oxf). 2008 Aug;69(2):189-96. doi: 10.1111/j.1365-2265.2008.03187.x. Epub 2008 Jan 23.

PMID:
18221403
38.

Anti-arthritis effects of vitamin K(2) (menaquinone-4)--a new potential therapeutic strategy for rheumatoid arthritis.

Okamoto H, Shidara K, Hoshi D, Kamatani N.

FEBS J. 2007 Sep;274(17):4588-94. Epub 2007 Aug 6.

39.

Influence of nutritional status on serum large N-truncated PTH, but not PTH(1-84) in hemodialysis patients.

Shidara K, Inaba M, Okuno S, Imanishi Y, Yamakawa T, Ishimura E, Kumeda Y, Nishizawa Y.

Biomed Pharmacother. 2007 Feb-Apr;61(2-3):142-7. Epub 2007 Jan 12.

PMID:
17270383
40.

[Significance of serum PTH (7-84) as a reliable nutritional marker in hemodialysis patients].

Shidara K, Inaba M, Kumeda Y, Imanishi Y, Tahara H, Ishimura E, Nishizawa Y, Yamakawa T, Okuno S.

Clin Calcium. 2005 Sep;15 Suppl 1:102-4; discussion 104-5. Japanese. Erratum in: Clin Calcium. 2006 Feb;16(2):149-52.

PMID:
16279018
41.

[A case of systemic lupus erythematosus complicated with psoriasis vulgaris].

Shidara K, Soejima M, Shiseki M, Ohta S, Nishinarita M.

Nihon Rinsho Meneki Gakkai Kaishi. 2003 Dec;26(6):341-5. Review. Japanese.

PMID:
14752935
42.
43.

Lack of synergistic association between human papillomavirus and ras gene point mutation in laryngeal carcinomas.

Shidara K, Suzuki T, Hara F, Nakajima T.

Laryngoscope. 1994 Aug;104(8 Pt 1):1008-12.

PMID:
8052064
44.

Two cases of nasopharyngeal branchial cyst.

Shidara K, Uruma T, Yasuoka Y, Kamei T.

J Laryngol Otol. 1993 May;107(5):453-5. Review.

PMID:
8326231

Supplemental Content

Loading ...
Support Center